FdaApplication
NDA 203312
Identifiers
- fda_app_no: NDA203312
Properties
| Property | Value |
|---|---|
| applicant_name | IMPAX LABORATORIES LLC |
| application_type | NDA |
| approval_date | 2015-01-07 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RYTARY | CARBIDOPA; LEVODOPA | 23.75MG;95MG | CAPSULE, EXTENDED RELEASE;ORAL |
| RYTARY | CARBIDOPA; LEVODOPA | 36.25MG;145MG | CAPSULE, EXTENDED RELEASE;ORAL |
| RYTARY | CARBIDOPA; LEVODOPA | 61.25MG;245MG | CAPSULE, EXTENDED RELEASE;ORAL |
| RYTARY | CARBIDOPA; LEVODOPA | 48.75MG;195MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products